MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Microglial activation"

  • 2019 International Congress

    Activity of Cerebral Networks, Amyloid and Microglia in Corticobasal Syndrome: the ActiGliA study

    C. Palleis, J. Levin, M. Brendel, L. Beyer, BS. Rauchmann, S. Loosli, E. Wlasich, K. Boetzel, A. Danek, R. Perneczky, C. Haass, G. Hoeglinger (Munich, Germany)

    Objective: The purpose of this prospective cohort study is to analyse the topographical and temporal relationship between cerebral microglia activity changes, network degeneration and atrophy…
  • 2019 International Congress

    A Study of Microglial Metabolism in Neuroinflammation

    T. Domenick, B. Cyr, R. Yost, M. Okun, V. Vedam-Mai (Gainesville, FL, USA)

    Objective: Targeting of microglial metabolism may be a potential therapeutic option for diseases such as PD [Parkinson’s Disease] and LBD [Lewy Body Dementia]. To establish…
  • 2018 International Congress

    Differential glial and neuronal response in Lipopolysaccharide induced Parkinson’s disease model: Modulation with Apocyanin and Curcumin

    N. Sharma, B. Nehru (Chandigarh, India)

    Objective: To understand the differential susceptibility of neuronal and glial populations to lipopolysaccharide (LPS) mediated insult in an animal model of PD. Also, to test…
  • 2018 International Congress

    Metabolomic Profiling of Activated Microglial Cells

    V. Vedam-Mai, T. Domenick, E. Gill, T. Garrett, R. Yost, M. Okun (Gainesville, FL, USA)

    Objective: To investigate metabolomic changes in SIM-A9 microglia in vitro following exposure to neuroinflammatory insult using high resolution mass spectrometry. Background: Microglial cells play an…
  • 2018 International Congress

    Bmal1 deficiency aggravates MPTP-induced dopaminergic cell death through promoting neuroinflammation

    C. Gu, W. Liu, X. Gu, F. Wang, Y. Yang, C. Liu (Su Zhou, China)

    Objective: Bmal1 is one of the most important central clock genes of circadian rhythm. Circadian rhythm dysfunction is one of the non-motor symptoms in Parkinson’s…
  • 2018 International Congress

    Neuroprotection effects of probiotics strains on a chronic MPTP-induced mouse model of Parkinson’s disease

    Y. Qian, X. Yang, S. Xu, Q. Xiao (Shanghai, China)

    Objective: To explore the effects of probiotics strains on the neuroinflammation and degeneration of dopaminergic neurons in chronic Parkinson’s disease (PD) mice model. Background: Microglia-mediated…
  • 2017 International Congress

    [11C]PK11195 PET in Alzheimer’s disease and progressive supranuclear palsy: the NIMROD study

    P. Vazquez Rodriguez, J. Rowe, J. O'Brien, F. Aigbirhio, T. Fryer, L. Su, E. Mak, A. Surendranathan, R. Borchert, S. Jones, R. Arnold, R. Bevan-Jones, L. Passamonti, Y. Hong (Cambridge, United Kingdom)

    Objective: Here we test whether the intensity and regional distribution of neuro-inflammation differs between Alzheimer's disease (AD), Progressive Supranuclear Palsy (PSP) and controls; and whether neuro-inflammation…
  • 2017 International Congress

    Study of neuroprotective effects of Ginsenside Rg3 , the prototypal epigenetic Sirtuin-1 activator, in targeting microglia activation and neurotrophic factor (NF) neural plasticity in MPTP model of Parkinson’s disease (PD)

    H. Raheb, J. Hou, S. Chiu (London, ON, Canada)

    Objective: 1) to examine whether the phyto-neurosteroid: Ginsenoside Rg3 recently demonstrated to activate the epigenetic SIRTI signaling, will rescue the motor impairment in rodent model…
  • 2017 International Congress

    Interactions between amyloid-β and microglial activation in Parkinson’s disease

    C. Ghadery, Y. Koshimori, J. Kim, S. Coakeley, M. Harris, L. Christopher, P. Rusjan, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)

    Objective: To evaluate the relationship between microglial activation and amyloid-β deposition in the brain using positron emission tomography (PET) in Parkinson’s disease (PD) with normal…
  • 2016 International Congress

    The role of neuroinflammation in the development of Parkinson’s disease dementia

    A. Kouli, R. Vuono, R.A. Barker, C.H. Williams-Gray (Cambridge, United Kingdom)

    Objective: To evaluate, at post-mortem, the pattern and characteristics of neuroinflammatory change in Parkinson's disease (PD) brain and to assess its relationship with aberrant alpha-synuclein,…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley